Search Results - "Pfannenstiel, Lukas W."

Refine Results
  1. 1

    Tumor-derived exosomes induce CD8 + T cell suppressors by Maybruck, Brian T, Pfannenstiel, Lukas W, Diaz-Montero, Marcela, Gastman, Brian R

    Published in Journal for immunotherapy of cancer (15-08-2017)
    “…The suppressive nature of immune cells in the tumor microenvironment plays a major role in regulating anti-tumor immune responses. Our previous work…”
    Get full text
    Journal Article
  2. 2

    Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma by Pfannenstiel, Lukas W., McNeilly, Corey, Xiang, Chaomei, Kang, Kai, Diaz-Montero, Claudia Marcella, Yu, Jennifer S., Gastman, Brian R.

    Published in Oncoimmunology (01-01-2019)
    “…Nearly half of melanoma patients develop brain metastases during the course of their disease. Despite advances in both localized radiation and systemic…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Immune-Checkpoint Blockade Opposes CD8 + T-cell Suppression in Human and Murine Cancer by Pfannenstiel, Lukas W, Diaz-Montero, C Marcela, Tian, Ye F, Scharpf, Joseph, Ko, Jennifer S, Gastman, Brian R

    Published in Cancer immunology research (01-03-2019)
    “…Immune-checkpoint blockade enhances antitumor responses against cancers. One cancer type that is sensitive to checkpoint blockade is squamous cell carcinoma of…”
    Get more information
    Journal Article
  6. 6

    Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice by Pfannenstiel, Lukas W., Lam, Samuel S.K., Emens, Leisha A., Jaffee, Elizabeth M., Armstrong, Todd D.

    Published in Cellular immunology (2010)
    “…Subclinical doses of Paclitaxel (PTX) given 1 day prior to a HER-2/ neu (neu)-targeted, granulocyte–macrophage colony stimulating factor (GM-CSF)-secreting…”
    Get full text
    Journal Article
  7. 7

    Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response by Ercolini, Anne M, Ladle, Brian H, Manning, Elizabeth A, Pfannenstiel, Lukas W, Armstrong, Todd D, Machiels, Jean-Pascal H, Bieler, Joan G, Emens, Leisha A, Reilly, R Todd, Jaffee, Elizabeth M

    Published in The Journal of experimental medicine (16-05-2005)
    “…A major barrier to successful antitumor vaccination is tolerance of high-avidity T cells specific to tumor antigens. In keeping with this notion, HER-2/neu…”
    Get full text
    Journal Article
  8. 8

    Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain by Demelash, Abeba, Pfannenstiel, Lukas W., Tannenbaum, Charles S., Li, Xiaoxia, Kalady, Matthew F., DeVecchio, Jennifer, Gastman, Brian R.

    Published in The Journal of biological chemistry (04-09-2015)
    “…Unlike other antiapoptotic Bcl-2 family members, Mcl-1 also mediates resistance to cancer therapy by uniquely inhibiting chemotherapy-induced senescence (CIS)…”
    Get full text
    Journal Article
  9. 9

    Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence by Demelash, Abeba, Pfannenstiel, Lukas W, Liu, Li, Gastman, Brian R

    Published in Oncotarget (25-04-2017)
    “…Mcl-1, a Bcl-2 family member, is highly expressed in a variety of human cancers and is believed to enhance tumorigenic potential and chemotherapy resistance…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Interleukin-7 Inhibits Tumor-Induced CD27-CD28- Suppressor T Cells: Implications for Cancer Immunotherapy by YUE ZHANG, PFANNENSTIEL, Lukas W, BOLESTA, Elzbieta, MONTES, Carolina L, XIAOYU ZHANG, CHAPOVAL, Andrei I, GARTENHAUS, Ronald B, STROME, Scott E, GASTMAN, Brian R

    Published in Clinical cancer research (01-08-2011)
    “…We have previously reported that many types of tumors can induce changes in human T cells that lead to the acquisition of suppressive function and phenotypic…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Raiding the pharmacy: genomic screening identifies known chemotherapies as negative regulators of MCL1 by Pfannenstiel, Lukas W, Demelash, Abeba, Gastman, Brian R

    Published in Genome medicine (27-06-2012)
    “…Despite multiple studies demonstrating the importance of the anti-apoptotic protein Mcl-1 in tumor cell survival and treatment resistance, a clinically…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Mcl-1 expression influcences CD8+ anti-tumor immunity by Pfannenstiel, Lukas W, Gastman, Brian R

    Published in Journal for immunotherapy of cancer (04-11-2015)
    “…The recent clinical successes of immunotherapies such as anti-PD-1 and anti-CTLA-4 antibody blockade have re-invigorated the idea that the immune system has…”
    Get full text
    Journal Article
  16. 16

    Abstract 1818: Developing an autologous humanized mouse model to assess responses to novel immunotherapeutics by Phoon, Yee Peng, Lopes, Jared E., Pfannenstiel, Lukas W., Diaz-Montero, C. Marcela, Tian, Ye F., Ernstoff, Marc S., Funchain, Pauline, Li, XiaoXia, Losey, Heather C., Winquist, Raymond J., Gastman, Brian R.

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Introduction: The development and FDA approval of drugs targeting the PD-1/PD-L1 axis has greatly shifted the paradigm of immunotherapy and has…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy by Pfannenstiel, Lukas W, Gastman, Brian R

    Published in Journal for immunotherapy of cancer (07-11-2013)
    “…The immune system has the potential to be a powerful tool to destroy tumors; however despite ample evidence of endogenous anti-tumor immune responses in many…”
    Get full text
    Journal Article
  19. 19

    Targeting immune checkpoint pathways overcomes tumor-induced CD8+ T cell suppression by Pfannenstiel, Lukas W, Gastman, Brian R

    Published in Journal for immunotherapy of cancer (06-11-2014)
    “…The immune system has the potential to be a powerful tool to destroy tumors. However despite ample evidence of anti-tumor immune responses in many patients, as…”
    Get full text
    Journal Article
  20. 20

    Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy by McNeilly, Corey D, Pfannenstiel, Lukas W, Xiang, Chaomei, Yu, Jennifer, Gastman, Brian R

    Published in Journal for immunotherapy of cancer (04-11-2015)
    “…IntroductionRadiation is an integral part of melanoma therapy, particularly for patients with symptomatic metastases. Efficient killing of tumor cells by…”
    Get full text
    Journal Article